Inactive Instrument

Analyst Reco. Inovio Pharmaceuticals Inc Nyse

Equities

US45773H1023

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 16	Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell	MT
Apr. 16	Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants	Apr. 16	MT
Oppenheimer Upgrades Inovio Pharmaceuticals to Outperform From Perform, $4 Price Target	Jan. 25	MT
RBC Trims Price Target on Inovio Pharmaceuticals to $2 From $3, Maintains Sector Perform Rating, Speculative Risk Qualifier	23-03-02	MT
Maxim Downgraded Inovio Pharmaceuticals to Hold From Buy	22-11-09	MT
BofA Securities Downgrades Inovio Pharmaceuticals to Underperform From Neutral With $2 Price Target	22-11-01	MT
Maxim Lowers Price Target for Inovio Pharmaceuticals to $5 From $11, Maintains Buy Rating	22-08-10	MT
RBC Reinstates Inovio Pharmaceuticals at Sector Perform-Speculative Risk, Assigns $4 Price Target, Awaiting 'More Attractive' Entry Point, 'Clearer Path for Value Creation'	22-07-19	MT
Oppenheimer Downgrades Inovio Pharmaceuticals to Perform From Outperform, Removes $30 Price Target	22-05-11	MT
RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Maintains Sector Perform-Speculative Risk Rating	22-03-02	MT
Maxim Group Adjusts Inovio Pharmaceuticals Price Target to $11 From $20, Maintains Buy Rating	22-02-02	MT
BofA Securities Upgrades Inovio Pharmaceuticals to Neutral From Underperform, Adjusts Price Target to $10 From $8	22-01-21	MT
Jefferies Assumes Inovio Pharmaceuticals at Hold, $6 Price Target	21-12-29	MT
INOVIO PHARMACEUTICALS : BofA Securities Downgrades Inovio Pharmaceuticals to Underperform From Neutral, Sets $8 Price Target	21-09-10	MT
INOVIO PHARMACEUTICALS : Jefferies Starts Inovio Pharmaceuticals at Hold With $9 Price Target	21-06-24	MT
INOVIO PHARMACEUTICALS : RBC Reduces Price Target on Inovio Pharmaceuticals to $7 From $8, Maintains Sector Perform, Speculative Risk	21-05-11	MT
INOVIO PHARMACEUTICALS : BofA Securities Initiates Coverage on Inovio Pharmaceuticals With Neutral Rating, $13 Price Target	21-03-23	MT
INOVIO PHARMACEUTICALS : Oppenheimer Starts Inovio Pharmaceuticals at Outperform With $35 Price Target	21-02-12	MT
INOVIO PHARMACEUTICALS : Roth Capital Downgrades Inovio Pharmaceuticals Back to Sell From Neutral; Price Target Remains $8	20-11-17	MT
INOVIO PHARMACEUTICALS : Roth Capital Upgrades Inovio Pharmaceuticals to Neutral From Sell; Price Target is $8	20-11-10	MT
INOVIO PHARMACEUTICALS : RBC Capital Adjusts Inovio Pharmaceuticals PT to $11 From $12, Maintains Sector Perform - Speculative Risk	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Inovio Pharmaceuticals Inc Nyse

Equities

US45773H1023

Analyst Reco.

Filters